Literature DB >> 25582817

A rapid progression of disease after surgical excision of a malignant rhabdoid tumor of the bladder.

Matthew E Sterling1, Christopher J Long2, Kristopher R Bosse3, Rochelle Bagatell3, Aseem R Shukla2.   

Abstract

Extrarenal malignant rhabdoid tumors (MRTs) are rare tumors with a poor prognosis. Five-year overall survival for patients with MRTs is poor at approximately 20%.(1) There are 5 case reports of histologically confirmed primary MRT of the bladder in pediatric patients. Herein, we report a case of an MRT of the bladder in a 14-year-old boy and discuss the preoperative evaluation, treatment options, and possible etiologies of metastasis after radical surgery.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Mesh：

Year:  2015        PMID： 25582817      PMCID： PMC4646707          DOI： 10.1016/j.urology.2014.11.011

Source DB:  PubMed          Journal:  Urology        ISSN： 0090-4295            Impact factor:   2.649


  15 in total

Review 1.  Pure rhabdoid tumor of the bladder.

Authors:  M Duvdevani; D Nass; Y Neumann; I Leibovitch; J Ramon; Y Mor
Journal:  J Urol       Date:  2001-12       Impact factor: 7.450

2.  Malignant rhabdoid tumours of the kidney (MRTKs), registered on recent SIOP protocols from 1993 to 2005: a report of the SIOP renal tumour study group.

Authors:  Marry M van den Heuvel-Eibrink; Harm van Tinteren; Harriet Rehorst; Aurore Coulombe; Catharine Patte; Beatriz de Camargo; Jan de Kraker; Ivo Leuschner; Rieneke Lugtenberg; Kathy Pritchard-Jones; Bengt Sandstedt; Filippo Spreafico; Norbert Graf; Gordan M Vujanic
Journal:  Pediatr Blood Cancer       Date:  2010-12-22       Impact factor: 3.167

Review 3.  Molecularly confirmed primary malignant rhabdoid tumor of the urinary bladder: implications of accurate diagnosis.

Authors:  Natasha Savage; Dan Linn; Colleen McDonough; Jeffrey M Donohoe; Arie Franco; Victor Reuter; Paul W Biddinger; Katherine W Eaton; Jaclyn A Biegel; Suash Sharma
Journal:  Ann Diagn Pathol       Date:  2011-07-19       Impact factor: 2.090

Review 4.  Update on the mechanisms of immune suppression of injury and immune modulation.

Authors:  E Faist; C Schinkel; S Zimmer
Journal:  World J Surg       Date:  1996-05       Impact factor: 3.352

Review 5.  Immunohistochemistry of INI1 expression: a new tool for old challenges in CNS and soft tissue pathology.

Authors:  Alexander R Judkins
Journal:  Adv Anat Pathol       Date:  2007-09       Impact factor: 3.875

6.  Malignant rhabdoid tumour of the bladder with immunohistochemical and ultrastructural evidence suggesting histiocytic origin.

Authors:  R L Carter; K P McCarthy; S Z al-Sam; P Monaghan; M Agrawal; T J McElwain
Journal:  Histopathology       Date:  1989-02       Impact factor: 5.087

7.  Extracranial malignant rhabdoid tumors in childhood: the Childrens Hospital Los Angeles experience.

Authors:  Catherine E Madigan; Saro H Armenian; Marcio H Malogolowkin; Leo Mascarenhas
Journal:  Cancer       Date:  2007-11-01       Impact factor: 6.860

Review 8.  The perioperative period is an underutilized window of therapeutic opportunity in patients with colorectal cancer.

Authors:  Gerben J van der Bij; Steven J Oosterling; Robert H J Beelen; Sybren Meijer; John C Coffey; Marjolein van Egmond
Journal:  Ann Surg       Date:  2009-05       Impact factor: 12.969

9.  Clinical and pathological features of paediatric malignant rhabdoid tumours.

Authors:  Daniel A Morgenstern; Sian Gibson; Tanya Brown; Neil J Sebire; John Anderson
Journal:  Pediatr Blood Cancer       Date:  2010-01       Impact factor: 3.167

10.  Intensive multimodality treatment for children with newly diagnosed CNS atypical teratoid rhabdoid tumor.

Authors:  Susan N Chi; Mary Ann Zimmerman; Xiaopan Yao; Kenneth J Cohen; Peter Burger; Jaclyn A Biegel; Lucy B Rorke-Adams; Michael J Fisher; Anna Janss; Claire Mazewski; Stewart Goldman; Peter E Manley; Daniel C Bowers; Anne Bendel; Joshua Rubin; Christopher D Turner; Karen J Marcus; Liliana Goumnerova; Nicole J Ullrich; Mark W Kieran
Journal:  J Clin Oncol       Date:  2008-12-08       Impact factor: 44.544
View more
  2 in total

1.  Loss of expression of the SWI/SNF complex is a frequent event in undifferentiated/dedifferentiated urothelial carcinoma of the urinary tract.

Authors:  Abbas Agaimy; Simone Bertz; Liang Cheng; Ondrej Hes; Kerstin Junker; Bastian Keck; Antonio Lopez-Beltran; Michael Stöckle; Bernd Wullich; Arndt Hartmann
Journal:  Virchows Arch       Date:  2016-06-23       Impact factor: 4.064

Review 2.  Unusual Faces of Bladder Cancer.

Authors:  Claudia Manini; José I López
Journal:  Cancers (Basel)       Date:  2020-12-10       Impact factor: 6.639
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.